This EDA investment supports the advanced pharmaceutical manufacturing (APM) cluster, led by the virginia biotechnology research partnership authority (activation capital), with boosting virginia's…

This $24.5 million Economic Development Administration Project Grant supports the Advanced Pharmaceutical Manufacturing Cluster led by the Virginia Biotechnology Research Partnership Authority to boost Virginia's domestic pharmaceutical supply chain. Funded projects will expand wet lab space and critical infrastructure in Central Virginia to develop an emerging pharmaceutical manufacturing corridor and engage local businesses to enhance the regional supply chain. The investment will also create partnerships between Virginia Commonwealth University and Virginia State University to develop career pathways in pharmaceutical manufacturing for underserved residents. These efforts aim to strengthen regional industry clusters in pharmaceuticals through job creation and U.S. competitiveness globally. The grant was awarded on September 8, 2022 by the Department of Commerce's Economic Development Administration under the Economic Adjustment Assistance program, which provides technical and infrastructure assistance to regions facing adverse economic changes.

This EDA investment supports the advanced pharmaceutical manufacturing (APM) cluster, led by the virginia biotechnology research partnership authority (activation capital), with boosting virginia's pharmaceutical industry by expanding the domestic supply chain for essential medicines and critical active pharmaceutical ingredients (apis). The projects funded as part of this award include expanding a nascent pharmaceutical manufacturing corridor in central virginia through investment in new wet lab space, development of critical infrastructure to sustain industrial capacity in petersburg, and engagement with local business to enhance the regional pharmaceutical supply chain. The project will also catalyze a new partnership between virginia commonwealth university and virginia state university to create new pathways for underserved residents to high-quality training and jobs in the pharmaceutical industry. Once implemented, the investment will help develop and strengthen regional industry clusters - all while embracing economic equity, creating good-paying jobs, and enhancing U.S. Competitiveness globally.